SCHEMBL4189154

SCHEMBL4189154

COc1ccc(S(=O)(=O)/C(=C\c2c(OC)cccc2OC)C(N)=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ F2 P00734 3/20 0.42
▸ PRSS1 P07477 3/20 0.42
▸ PRSS2 P07478 3/20 0.42
▸ PRSS3 P35030 3/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ ABCG2 Q9UNQ0 2/20 0.41
▸ PKM P14618 3/20 0.40
▸ MAOB P27338 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ GAA P10253 3/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ KEAP1 Q14145 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4189148 1.00 ALDH1A1 (0.44) ALDH1A1KMT2ARAB9ASMN1; SMN2F2
SCHEMBL4189160 1.00 ALDH1A1 (0.44) ALDH1A1KMT2ARAB9ASMN1; SMN2F2
SCHEMBL4172509 0.89 ABCG2 (0.46) ALDH1A1KMT2ARAB9ASMN1; SMN2F2
SCHEMBL4172505 0.89 ABCG2 (0.46) ALDH1A1KMT2ARAB9ASMN1; SMN2F2
SCHEMBL4172500 0.89 ABCG2 (0.46) ALDH1A1KMT2ARAB9ASMN1; SMN2F2
SCHEMBL4186031 0.89 ABCG2 (0.43) ALDH1A1KMT2ARAB9ASMN1; SMN2ABCG2
SCHEMBL4186037 0.89 ABCG2 (0.43) ALDH1A1KMT2ARAB9ASMN1; SMN2ABCG2
SCHEMBL4186035 0.89 ABCG2 (0.43) ALDH1A1KMT2ARAB9ASMN1; SMN2ABCG2
SCHEMBL4174354 0.83 KMT2A (0.46) ALDH1A1KMT2ARAB9ASMN1; SMN2MEN1
SCHEMBL4174365 0.83 KMT2A (0.46) ALDH1A1KMT2ARAB9ASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-07-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof ARSA, STS, SULT2A1 ALDH1A1 249/4885KMT2A 469/4885RAB9A 2921/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback